These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12954325)

  • 21. Funding, conflicts, and paradigms.
    Gelenberg AJ
    J Clin Psychiatry; 2005 May; 66(5):554. PubMed ID: 15889939
    [No Abstract]   [Full Text] [Related]  

  • 22. Research accountability and financial conflicts of interest in industry-sponsored clinical research: a review.
    Tereskerz PM
    Account Res; 2003; 10(3):137-58. PubMed ID: 14979317
    [No Abstract]   [Full Text] [Related]  

  • 23. Where will new drugs come from?
    Lancet; 2011 Jan; 377(9760):97. PubMed ID: 21215869
    [No Abstract]   [Full Text] [Related]  

  • 24. US doctors earn speaking and consulting fees from drug companies that sponsor their research.
    McCarthy M
    BMJ; 2014 Mar; 348():g2410. PubMed ID: 24677695
    [No Abstract]   [Full Text] [Related]  

  • 25. UK Cancer Drugs Fund to reassess 42 agents.
    Cagney H
    Lancet Oncol; 2015 Jan; 16(1):e8. PubMed ID: 25638560
    [No Abstract]   [Full Text] [Related]  

  • 26. America's other drug problem: how the drug industry distorts medicine and politics.
    Relman AS; Angell M
    New Repub; 2002 Dec; 227(25):27-41. PubMed ID: 12561803
    [No Abstract]   [Full Text] [Related]  

  • 27. The NIH budget and the future of biomedical research.
    Loscalzo J
    N Engl J Med; 2006 Apr; 354(16):1665-7. PubMed ID: 16625006
    [No Abstract]   [Full Text] [Related]  

  • 28. Personalized medicine: potential impact on the biopharmaceutical industry.
    Malik NN; Khan Y
    Drug Discov Today; 2010 Nov; 15(21-22):881-3. PubMed ID: 20833263
    [No Abstract]   [Full Text] [Related]  

  • 29. Ghost story: at medical journals, writers paid by industry play big role.
    Mathews AW
    Wall St J (East Ed); 2005 Dec; ():A1, A8. PubMed ID: 16506304
    [No Abstract]   [Full Text] [Related]  

  • 30. Stimulus funds force hard look at comparative effectiveness research.
    Tuma RS
    J Natl Cancer Inst; 2009 Aug; 101(15):1036-9. PubMed ID: 19638502
    [No Abstract]   [Full Text] [Related]  

  • 31. Cultivating and investing in clinical research in China.
    Zhang J; Huang H; Shen X
    Lancet; 2015 Oct; 386(10002):1506-8. PubMed ID: 26466054
    [No Abstract]   [Full Text] [Related]  

  • 32. The Economic Contribution of Industry-Sponsored Pharmaceutical Clinical Trials.
    Tran DT; Akpinar I; Fedorak R; Jonsson E; Mackey J; Richer L; Jacobs P
    J Pharm Pharm Sci; 2017; 20(1):407-414. PubMed ID: 29197429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Foreign free riders and the high price of US medicines.
    Light DW; Lexchin J
    BMJ; 2005 Oct; 331(7522):958-60. PubMed ID: 16239695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Independent clinical research in oncology].
    Perrone F
    Suppl Tumori; 2004; 3(4):S37-40. PubMed ID: 15206208
    [No Abstract]   [Full Text] [Related]  

  • 35. Associations Between Industry Sponsorship and Results of Cost-effectiveness Analyses of Drugs Used in Breast Cancer Treatment.
    Lane JD; Friedberg MW; Bennett CL
    JAMA Oncol; 2016 Feb; 2(2):274-6. PubMed ID: 26658959
    [No Abstract]   [Full Text] [Related]  

  • 36. Cetuximab in colon cancer.
    Holmer AF
    N Engl J Med; 2004 Oct; 351(15):1575-6; author reply 1575-6. PubMed ID: 15470223
    [No Abstract]   [Full Text] [Related]  

  • 37. Charities tied to doctors get drug industry gifts.
    Abelson R
    N Y Times Web; 2006 Jun; ():A1, C4. PubMed ID: 16838451
    [No Abstract]   [Full Text] [Related]  

  • 38. Will the RACE for Children Act lead to new treatments for pediatric cancer?
    Fink JL
    Cancer; 2017 Jan; 123(2):189. PubMed ID: 28067946
    [No Abstract]   [Full Text] [Related]  

  • 39. Outlook: the profit problem in antibiotic R&D.
    Nathan C; Goldberg FM
    Nat Rev Drug Discov; 2005 Nov; 4(11):887-91. PubMed ID: 16247440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Academia-industry alliance: Belfer Institute and sanofi-aventis collaborate to develop new cancer therapeutics.
    Dis Model Mech; 2010; 3(11-12):669. PubMed ID: 21030419
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.